ProCE Banner Activity

Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: An Update from ASCO 2022

Podcast Episodes

Listen as Beth Sandy, MSN, CRNP, discusses some of the latest key data on immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) recently reported at the American Society of Clinical Oncology (ASCO) 2022 Annual Conference.

Released: June 27, 2022

Expiration: June 26, 2023

Begin Activity



Beth Sandy

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania


This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, a member of the Roche Group; Merck Sharp & Dohme Corp.; and Regeneron Pharmaceuticals, Inc and Sanofi.

Provided by

ProCE Banner

Target Audience

Oncology NPs, PAs, and nurses


Beth Sandy, MSN, CRNP: consultant: Amgen, AstraZeneca, Janssen, Jazz, Merck, Takeda.



Additional Information

Program Medium

This program has been made available online.